NCT06860386 2026-03-06
Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Suspended
H. Lee Moffitt Cancer Center and Research Institute
Hoosier Cancer Research Network
M.D. Anderson Cancer Center
Emory University
Sorrento Therapeutics, Inc.
AstraZeneca
Gustave Roussy, Cancer Campus, Grand Paris